|
⚲
|
| Keyboard |
| CAD Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002157566 |
| Sale | 2026-09-17 (10.0 M Offered, 4.0 M Sold) |
| Fund | |
| Phone | 6464567684 |
| Address | 6 St Johns Ln New York, NY 10013 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-10-02 (D) |
| Exemption | 506(b) |
| Remaining | $6,000,000 |
| Duration | One year or less |
| Revenue | No Revenues |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Sorina Buri | Director | |
| Christopher Teas | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Sestante Capital LLC
✚
|
NY | |
|
BlueCrest Capital Management New York LP
✚
|
NY | |
|
The Mannsion Group LLC
✚
|
NY | |
|
Wolfe Research Advisors LLC
✚
|
NY | |
|
Millville Opportunities Management LLC
✚
|
NY | |
|
Vorynto Exchange Ltd
✚
|
NY | |
|
Altalis Capital Management LLC
✚
|
NY | |
|
Duane Park Capital Management LP
✚
|
NY | |
|
Calvion Capital Management LP
✚
|
NY | |
|
Harbor Spring Capital LLC
✚
|
NY |